NICE widens eczema treatment options

NICE has recommended the use of alitretinoin as a treatment option for adults with severe chronic hand eczema who have not responded to treatment with topical corticosteroids.

The guidance, published last week, states that alitretinoin treatment should be stopped as soon as an adequate response has been achieved.

The treatment should not be continued for longer than 24 weeks if no improvement in the condition has been seen.

Dr Stephen Kownacki, chairman of the Primary Care Dermatology Society and a GP in Northampton, welcomed the decision by NICE.

 ‘GPs can now refer those patients who have run out of treatment options to be considered for alitretinoin,' he said.


Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in